• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase

tetano

Editor, Senior Moderator
Respir Res


. 2020 Jun 29;21(1):163.
doi: 10.1186/s12931-020-01429-6.
Impact of Coronavirus Disease 2019 on Pulmonary Function in Early Convalescence Phase

Yiying Huang[SUP] 1 2 [/SUP], Cuiyan Tan[SUP] 1 [/SUP], Jian Wu[SUP] 1 [/SUP], Meizhu Chen[SUP] 1 [/SUP], Zhenguo Wang[SUP] 1 [/SUP], Liyun Luo[SUP] 3 [/SUP], Xiaorong Zhou[SUP] 1 [/SUP], Xinran Liu[SUP] 1 [/SUP], Xiaoling Huang[SUP] 1 [/SUP], Shican Yuan[SUP] 1 [/SUP], Chaolin Chen[SUP] 1 [/SUP], Fen Gao[SUP] 1 [/SUP], Jin Huang[SUP] 1 [/SUP], Hong Shan[SUP] 2 [/SUP], Jing Liu[SUP] 4 5 [/SUP]


AffiliationsExpand

Abstract

Objective: This study investigated the influence of Coronavirus Disease 2019 (COVID-19) on lung function in early convalescence phase.
Methods: A retrospective study of COVID-19 patients at the Fifth Affiliated Hospital of Sun Yat-sen University were conducted, with serial assessments including lung volumes (TLC), spirometry (FVC, FEV1), lung diffusing capacity for carbon monoxide (DLCO),respiratory muscle strength, 6-min walking distance (6MWD) and high resolution CT being collected at 30 days after discharged.
Results: Fifty-seven patients completed the serial assessments. There were 40 non-severe cases and 17 severe cases. Thirty-one patients (54.3%) had abnormal CT findings. Abnormalities were detected in the pulmonary function tests in 43 (75.4%) of the patients. Six (10.5%), 5(8.7%), 25(43.8%) 7(12.3%), and 30 (52.6%) patients had FVC, FEV1, FEV1/FVC ratio, TLC, and DLCO values less than 80% of predicted values, respectively. 28 (49.1%) and 13 (22.8%) patients had PImax and PEmax values less than 80% of the corresponding predicted values. Compared with non-severe cases, severe patients showed higher incidence of DLCO impairment (75.6%vs42.5%, p = 0.019), higher lung total severity score (TSS) and R20, and significantly lower percentage of predicted TLC and 6MWD. No significant correlation between TSS and pulmonary function parameters was found during follow-up visit.
Conclusion: Impaired diffusing-capacity, lower respiratory muscle strength, and lung imaging abnormalities were detected in more than half of the COVID-19 patients in early convalescence phase. Compared with non-severe cases, severe patients had a higher incidence of DLCO impairment and encountered more TLC decrease and 6MWD decline.

Keywords: COVID-19; Early convalescence; Lung function; Respiratory muscle strength.
 
Back
Top Bottom